Balyasny Asset Management »

Compass Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.9M 2.8M 3.50
2025-03-31 $631k 332k 1.90
2023-03-31 $88k 27k 3.27
2022-12-31 $145k 29k 5.03

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
Enavate Sciences GP
BlackRock
Vanguard Group
Adage Capital Partners GP
MPM Oncology Impact Management
BVF
Rock Springs Capital Management
FMR
Millennium Management
State Street Corporation

View all funds holding Compass Therapeutics